{
    "eid": "2-s2.0-84971418688",
    "title": "Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism",
    "cover-date": "2016-08-28",
    "subject-areas": [
        {
            "$": "Cancer Research",
            "@code": "1306"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "Antiestrogens",
        "Breast cells",
        "Differentiation",
        "HEXIM1",
        "HMBA",
        "Metastasis"
    ],
    "authors": [
        "Wannarasmi Ketchart"
    ],
    "citedby-count": 9,
    "ref-count": 41,
    "ref-list": [
        "Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: A phase II clinical trial with a differentiation-inducing agent",
        "Phase I Trial and Clinical Pharmacological Evaluation of Hexamethylene Bisacetamide Administration by Ten-Day Continuous Intravenous Infusion at Twenty-eight-Day Intervals",
        "Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation",
        "Phase I Trial Using Adaptive Control Dosing of Hexamethylene Bisacetamide (NSC 95580)",
        "Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation",
        "Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor",
        "HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b",
        "Inhibition of P-TEFb (CDK9/cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA",
        "HEXIM1 regulates 17\u03b2-estradiol/estrogen receptor-\u03b1-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb",
        "HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens",
        "Brd4 and HEXIM1: Multiple roles in P-TEFb regulation and cancer",
        "Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor",
        "HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland",
        "Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis",
        "The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1",
        "Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors",
        "HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist",
        "Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma",
        "Identification of HEXIM1 as a positive regulator of p53",
        "HEXIM1 is a critical determinant of the response to tamoxifen",
        "Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF\u03baB activity: Implications for cancer therapy",
        "Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse",
        "HMBA induces activation of a caspase-independent cell death pathway               to overcome P-glycoprotein-mediated multidrug resistance",
        "Lead optimization of HMBA to develop potent HEXIM1 inducers",
        "The quinone reductase gene: A unique estrogen receptor-regulated gene that is activated by antiestrogens",
        "DHT selectively reverses Smad3-mediated/TGF-\u03b2-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells",
        "HEXIM1 down-regulates hypoxia-inducible factor-1\u03b1 protein stability",
        "Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells",
        null,
        "Solid tumor differentiation therapy - Is it possible?",
        "Development of a fluorescent reporter system to delineate cancer stem cells in triple-negative breast cancer",
        "HEXIM1 down-regulates hypoxia-inducible factor-1\u03b1 protein stability",
        "Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases",
        "Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription",
        "P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II",
        "A 2009 update on the treatment of patients with hormone receptor-positive breast cancer",
        "Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance",
        "Cell cycle control by steroid hormones",
        "Tamoxifen in the treatment of breast cancer",
        "Predictors of response to aromatase inhibitors",
        "Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1"
    ],
    "affiliation": [
        {
            "affiliation-city": "Cleveland",
            "affilname": "CASE School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Cleveland",
            "affilname": "Cleveland Clinic Foundation",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cleveland",
            "affilname": "Cleveland State University",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Cancer Institute",
        "National Cancer Institute"
    ]
}